comprehensive -WSS

comprehensive

author：explore 2025-09-14 18:28:13 - browse：38276

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Three trends to watch in biotech in 2024

WSS

Editas, Vertex strike deal on CRISPR

Parkinson’s finding may lead to tests and, someday, treatments

Humana cuts profit projections as Medicare Advantage costs soar

Keeping primary care docs in field isn't impossible, says AAFP CEO

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Medicare drug price negotiation hasn't dried up venture capital

focus

comprehensive

entertainment

Cancer drug shortages should be causing more outrage

Why health records don't always know when patients are dead

Peter Hotez and the public health issue of online harassment

Carvykti CAR

State Dept. review finds Biden bears some blame for Afghanistan failures

Keeping primary care docs in field isn't impossible, says AAFP CEO

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: The latest on Moderna, Apellis, and Merck

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Independent physicians launch a new lobbying group

focus

AI generated plenty of interest at JPM but not a lot of trust

AI generated plenty of interest at JPM but not a lot of trust

The tragedy of Johnson & Johnson’s Covid vaccine

Think you might have Covid

In Spain, a hospital brews its own CAR

Readout Newsletter: The latest on Moderna, Apellis, and Merck

hotspot

focus

focus

hotspot